S03 Ep. 26 Sequencing Therapies in NMIBC Management with Dr. Mark Tyson and Dr. Suzanne Merrill episode artwork

EPISODE · Oct 7, 2025 · 1H

S03 Ep. 26 Sequencing Therapies in NMIBC Management with Dr. Mark Tyson and Dr. Suzanne Merrill

from BackTable Tumor Board · host BackTable Inc.

New FDA-approved therapies for BCG-refractory non-muscle invasive bladder cancer (NMIBC)–where do they fit in the treatment algorithm, and how do you administer them? This installment of the 2025 NMIBC Creator Weekend™ series features host Dr. Bogdana Schmidt, assistant professor of Urologic Oncology at the University of Utah, and leading urologic oncologists Dr. Mark Tyson from Mayo Clinic Arizona and Dr. Suzanne Merrill from Colorado Urology. --- This podcast is supported by: ⁠Ferring Pharmaceuticals⁠ --- SYNPOSIS The discussion delves into the newest treatment strategies and FDA-approved therapies for non-muscle invasive bladder cancer with an emphasis on BCG-refractory patients. They highlight their approaches to sequencing therapies, the real-world applicability of these treatments, and the impact of patient factors in clinical decision-making. The panel also explores emerging trials and innovative treatment mechanisms, emphasizing the importance of personalized care in oncology. --- TIMESTAMPS 00:00 - Introduction05:09 - Challenges and Strategies in Treatment10:55 - Bladder Sparing Therapies21:41 - Practical Tips for Therapy Administration30:39 - Challenges and Considerations in Reinduction37:05 - Clinical Trials and Future Directions44:11 - Counseling Patients on Treatment Options57:36 - Concluding Thoughts and Future Outlook

New FDA-approved therapies for BCG-refractory non-muscle invasive bladder cancer (NMIBC)–where do they fit in the treatment algorithm, and how do you administer them? This installment of the 2025 NMIBC Creator Weekend™ series features host Dr. Bogdana Schmidt, assistant professor of Urologic Oncology at the University of Utah, and leading urologic oncologists Dr. Mark Tyson from Mayo Clinic Arizona and Dr. Suzanne Merrill from Colorado Urology. --- This podcast is supported by: ⁠Ferring Pharmaceuticals⁠ --- SYNPOSIS The discussion delves into the newest treatment strategies and FDA-approved therapies for non-muscle invasive bladder cancer with an emphasis on BCG-refractory patients. They highlight their approaches to sequencing therapies, the real-world applicability of these treatments, and the impact of patient factors in clinical decision-making. The panel also explores emerging trials and innovative treatment mechanisms, emphasizing the importance of personalized care in oncology. --- TIMESTAMPS 00:00 - Introduction05:09 - Challenges and Strategies in Treatment10:55 - Bladder Sparing Therapies21:41 - Practical Tips for Therapy Administration30:39 - Challenges and Considerations in Reinduction37:05 - Clinical Trials and Future Directions44:11 - Counseling Patients on Treatment Options57:36 - Concluding Thoughts and Future Outlook

NOW PLAYING

S03 Ep. 26 Sequencing Therapies in NMIBC Management with Dr. Mark Tyson and Dr. Suzanne Merrill

0:00 1:00:53

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

API Intersection Stoplight Building a successful API requires more than just coding. It starts with collaborative design, focuses on creating a great developer experience, and ends with getting your company on board, maintaining consistency, and maximizing your API’s profitability.In the API Intersection, you’ll learn from experienced API practitioners who transformed their organizations, and get tangible advice to build quality APIs with collaborative API-first design.Jason Harmon brings over a decade of industry-recognized REST API experience to discuss topics around API design, governance, identity/auth versioning, and more.They’ll answer listener questions, and discuss best practices on API design (definition, modeling, grammar), Governance (multi-team design, reviewing new API’s), Platform Transformation (culture, internal education, versioning) and more.They’ll also chat with experienced API practitioners from a wide array of industries to draw out practical takeaways and insights you can use.H PDF feed of Interpreter: A Journal of Latter-day Saint Faith and Scholarship PDF feed of Interpreter: A Journal of Latter-day Saint Faith and Scholarship The Interpreter Foundation is a nonprofit educational organization focused on the scriptures of The Church of Jesus Christ of Latter-day Saints (the Book of Mormon, the Pearl of Great Price, the Bible, and the Doctrine and Covenants), early LDS history, and related subjects. All publications in its journal, Interpreter: A Journal of Latter-day Saint Faith and Scholarship, are peer-reviewed and made available as free internet downloads or through at-cost print-on-demand services. Other posts on the website are not necessarily peer-reviewed, but are approved by Interpreter’s Executive Board.Our goal is to increase understanding of scripture through careful scholarly investigation and analysis of the insights provided by a wide range of ancillary disciplines, including language, history, archaeology, literature, culture, ethnohistory, art, geography, law, politics, philosophy, statistics, etc. Interpreter will also publish articles advocating the authenticity and historicity Passive Investing Podcast The Real Estate Women The Passive Investing Podcast is a round table discussion where we teach you how to create a stream of passive income through Multi Family investing. Crystal, Candy, Colleen & Tamara dive into the classroom, board room and living room on Multi Family real estate investing, with Guests Matt Pichney, Rod Khleif, and Julie Holly pulling up a chair to share stories and insight on their areas of expertise. Whether you’re trying to jump into real estate to free yourself from the grind of the 9-5, to build a stream of passive income or to create generational wealth, join us at the table! Brasher Warning Brasher Warning Brasher Warning: Exploring the Skies, One Close Call at a Time: Take a deep dive into the intense world of aviation incidents with Brasher Warning, a podcast that explores the stories behind near misses, full-blown accidents, and everything in between. As a busy Chicago-based air traffic controller, husband, and father of two amazing girls, my time is limited, but my passion for aviation safety has never wavered. Thanks to cutting-edge AI, I’ve discovered a way to bring this passion back into my life—and now, into yours. Each episode unpacks real-life aviation events using detailed reports, including those from the National Transportation Safety Board (NTSB), weaving them into seamless, digestible narratives. Whether on my way to work, during a quick break, or while I’m getting ready for the day, AI allows me to analyze mountains of data and transform it into compelling stories that inform and entertain. And now I’m sharing that with you. Whether you’re an aviation enthusiast, a cur

Frequently Asked Questions

How long is this episode of BackTable Tumor Board?

This episode is 1 hour and 0 minutes long.

When was this BackTable Tumor Board episode published?

This episode was published on October 7, 2025.

What is this episode about?

New FDA-approved therapies for BCG-refractory non-muscle invasive bladder cancer (NMIBC)–where do they fit in the treatment algorithm, and how do you administer them? This installment of the 2025 NMIBC Creator Weekend™ series features host Dr....

Can I download this BackTable Tumor Board episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!